THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL

被引：73
作者：
LENNARD, MS
JACKSON, PR
FREESTONE, S
TUCKER, GT
RAMSAY, LE
WOODS, HF
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 17卷 / 06期
关键词：
D O I：
10.1111/j.1365-2125.1984.tb02403.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：679 / 685
页数：7
相关论文
共 22 条
[1]  
BAI SA, 1983, J PHARMACOL EXP THER, V224, P62
[2]  
CLEAVELAND CR, 1972, CLIN PHARMACOL THER, V13, P181
[3]   PLASMA PROPRANOLOL LEVELS IN QUANTITATIVE ASSESSMENT OF BETA-ADRENERGIC BLOCKADE IN MAN [J].
COLTART, DJ ;
SHAND, DG .
BRITISH MEDICAL JOURNAL, 1970, 3 (5725) :731-&
[4]  
DAYER P, 1983, SCHWEIZ MED WSCHR, V113, P295
[5]   DEFECTIVE HYDROXYLATION OF BUFURALOL ASSOCIATED WITH SIDE-EFFECTS OF THE DRUG IN POOR METABOLIZERS [J].
DAYER, P ;
KUBLI, A ;
KUPFER, A ;
COURVOISIER, F ;
BALANT, L ;
FABRE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :750-752
[6]   PHARMACOLOGY OF 4-HYDROXYPROPRANOLOL, A METABOLITE OF PROPRANOLOL [J].
FITZ GERALD, JD ;
ODONNELL, SR .
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (01) :222-+
[7]  
LENNARD MS, 1983, NEW ENGL J MED, V308, P965
[8]   DEFECTIVE METABOLISM OF METOPROLOL IN POOR HYDROXYLATORS OF DEBRISOQUINE [J].
LENNARD, MS ;
SILAS, JH ;
FREESTONE, S ;
TREVETHICK, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :301-303
[9]   OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE [J].
LENNARD, MS ;
SILAS, JH ;
FREESTONE, S ;
RAMSAY, LE ;
TUCKER, GT ;
WOODS, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1558-1560
[10]  
LENNARD MS, 1983, PHARM INT, V4, P61
123